AU1807188A - Human monoclonal antibodies binding determinants of gram negative bacteria - Google Patents

Human monoclonal antibodies binding determinants of gram negative bacteria

Info

Publication number
AU1807188A
AU1807188A AU18071/88A AU1807188A AU1807188A AU 1807188 A AU1807188 A AU 1807188A AU 18071/88 A AU18071/88 A AU 18071/88A AU 1807188 A AU1807188 A AU 1807188A AU 1807188 A AU1807188 A AU 1807188A
Authority
AU
Australia
Prior art keywords
monoclonal antibodies
human monoclonal
negative bacteria
gram negative
antibodies binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18071/88A
Inventor
Richard C. Harmon
Lowell S. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xoma Corp
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Publication of AU1807188A publication Critical patent/AU1807188A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1009—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/255—Salmonella (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS
AU18071/88A 1987-04-10 1988-04-01 Human monoclonal antibodies binding determinants of gram negative bacteria Abandoned AU1807188A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3677687A 1987-04-10 1987-04-10
US036776 1998-03-09

Publications (1)

Publication Number Publication Date
AU1807188A true AU1807188A (en) 1988-11-04

Family

ID=21890590

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18071/88A Abandoned AU1807188A (en) 1987-04-10 1988-04-01 Human monoclonal antibodies binding determinants of gram negative bacteria

Country Status (5)

Country Link
KR (1) KR890700832A (en)
AU (1) AU1807188A (en)
IL (1) IL85974A0 (en)
WO (1) WO1988008135A1 (en)
ZA (1) ZA882456B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
EP3049442A4 (en) 2013-09-26 2017-06-28 Costim Pharmaceuticals Inc. Methods for treating hematologic cancers
JOP20200094A1 (en) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc Antibody molecules to pd-1 and uses thereof
JOP20200096A1 (en) 2014-01-31 2017-06-16 Children’S Medical Center Corp Antibody molecules to tim-3 and uses thereof
US9993551B2 (en) 2014-09-13 2018-06-12 Novartis Ag Combination therapies of EGFR inhibitors
CA3004790A1 (en) * 2015-11-10 2017-05-18 Visterra, Inc. Lipopolysaccharide binding antibody-antimicrobial peptide conjugates and uses thereof
AU2018209940A1 (en) 2017-01-18 2019-07-11 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria

Also Published As

Publication number Publication date
IL85974A0 (en) 1988-09-30
WO1988008135A1 (en) 1988-10-20
ZA882456B (en) 1988-09-29
KR890700832A (en) 1989-04-27

Similar Documents

Publication Publication Date Title
AU6323686A (en) Monoclonal antibodies binding determinants of gram negative bacteria
AU2782789A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
AU550364B2 (en) Immunogen of lidocaine-protein conjugate and antibodies derived therefrom
AU2493184A (en) Specific cea-family antigens, antibodies specific thereto and their methods of use
AU6036690A (en) Human monoclonal antibodies to hiv-1mn gp 120
AU1807188A (en) Human monoclonal antibodies binding determinants of gram negative bacteria
ZA867342B (en) Monoclonal antibodies binding determinants of grams negative bacteria
EP0285511A3 (en) Monoclonal antibodies and their uses
EP0310413A3 (en) Immobilized antibodies
AU2383288A (en) Human anti-rh(d) monoclonal antibodies
GB2212500B (en) Immobilized antibodies
AU3923293A (en) Human monoclonal antibodies and methods for human monoclonal antibody production
GB8722019D0 (en) Human anti-rh(d)monoclonal antibodies
AU2111088A (en) Carrier of antigen or antibody
AU7649187A (en) Preparation of monoclonal antibodies
AU2644088A (en) Urease antigen product & process
GB8726230D0 (en) Antibodies
IL86960A0 (en) Preparation of human monoclonal antibodies
AU5675790A (en) Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
GB2214509B (en) Human monoclonal antibody to p.aeruginosa and gram negative bacteria: its production and use
AU618720B2 (en) Monoclonal antibodies
AU8864791A (en) Antibodies and methods for diagnosis and treatment of diabetes
ZW9888A1 (en) Monoclonal antibodies and methods for diagnosis of pytophthora infection
AU2389588A (en) Human anti-rh(d) monoclonal antibodies
AU5217890A (en) Monoclonal antibodies in vaccine formulations